US FDA’s Vaccine Office Emerges From Non-COVID-19 Backlog

 
• By Derrick Gingery
  
backlog
CBER stopped deprioritizing non-COVID-19 submissions in 2023. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet